NEW YORK — Spatial biology startup Resolve Biosciences has partnered with optics firm Zeiss on the development of new microscopy and 3D imaging technologies, the German companies said on Tuesday.
Resolve, which was founded by former Qiagen executives and emerged from stealth mode in late 2020 following a $24 million Series A round, has developed a spatial biology analysis platform — dubbed Molecular Cartography — for viewing transcriptome activity at subcellular resolution. The platform includes Zeiss microscopy technology and is slated for commercial launch later this year.
Under the terms of their collaboration, Zeiss, headquartered in Jena, and Resolve, based in Monheim am Rhein, will develop new optical systems and computational approaches to enhance the Molecular Cartography workflow. Resolve said that it aims to eventually add DNA, protein, and metabolomic data layers to the technology.
Financial and other terms of the agreement were not disclosed.